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In this issue of EBioMedicine, Christian Münz and colleagues show autophagy could be related to a secretory pathway, and that the virus
that Epstein–Barr Virus (EBV) induces an accumulation of membranes
related to the cellular autophagy pathway, and that an autophagic
marker can be found in EBV particles (Nowag et al., 2014). This
suggests that autophagic membranes participate in generation of the
viral envelope. This suggests new avenues for inhibiting gamma-
herpesvirus formation and the possibility of antigenicity from autopha-
gicmarkers on virions. To understand the importance of this ﬁnding, we
need to examine autophagy and its relationship to viruses.
Autophagy is a constitutive pathway of protein, lipid, and organelle
breakdown that serves to maintain cellular homeostasis. During times
of stress, starvation, or developmental programming, autophagy in-
creases in cells. Autophagy is marked by the generation of unique
double-membraned vesicles that encompass cytoplasmic cargo for deg-
radation. The pathway is regulated at several stages, including forma-
tion of the autophagosome and the stepwise maturation of the
organelle, by vesicle fusion, into an acidic, degradative autolysosome.
This regulatory precisionmeans that autophagosomes can formwithout
maturing into degradative vesicles, such that thepresence of autophagic
vesicles does not necessarily mean active autophagy.
In the early days of the virus-autophagy ﬁeld, two non-exclusive
theories were advanced about the relationship between infection and
autophagosome formation. First, it was suggested that autophagy acts
as a direct, physical component of innate immunity, degrading nascent
virions and viral components to inhibit infection. Certainly this is true
for some viruses; however, we now know that this is far from a univer-
sal phenomenon, and that autophagy is often triggered by the pathogen
as a pro-viral pathway. The second theory was that the surface
autophagosomes serve as a physical location or substrate for viral pro-
cesses; notably, in the case of RNA viruses, RNA replication has been re-
ported to take place on the autophagosome surface (Richards et al.,
2014). There is ample evidence that this does in fact occur, but recent
work has demonstrated that autophagosomes serve purposes later in
viral life cycles, including roles in physical assembly, maturation, and
cellular exit of virions, for both RNA and DNA viruses. TheMünz group's
work highlights the broad application of this viral strategy (Nowag et al.,
2014).
In 2005, the lab of Karla Kirkegaard reported that regulating levels of
cellular autophagy altered the levels of extracellular poliovirus prior to
cellular lysis. This phenomenon was termed Autophagic exitWith Out
Lysis, or AWOL (Jackson et al., 2005). This led to a hypothesis thatDOI of original article: http://dx.doi.org/10.1016/j.ebiom.2014.11.007.
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time, no evidence that such a pathway existed, it was later shown that
autophagy does feed into non-canonical cellular secretion. This uncon-
ventional secretory mechanism, ﬁrst identiﬁed in yeast and amoebae,
is not mediated by ER signal sequences and appears to be a relatively
minor pathway (Pfeffer, 2010). However, the existence of this secretory
mechanism does reveal that autophagy can be a pathway of cell exit. A
major topology problem remains: namely, howmight a virus transverse
multiple lipid bilayers (two on the autophagosome, and one on the plas-
ma membrane) to be released from cells without a surrounding mem-
brane? Recent papers have indicated that picornaviruses, including
Hepatitis A Virus and Coxsackievirus B3, are often released in membra-
nous vesicles and are therefore not purely non-enveloped. In the case of
Coxsackievirus, the membrane surrounding extracellular viral particles
contains markers of autophagy (Robinson et al., 2014). This suggests
that fusion of the outer autophagic membrane with the plasma mem-
brane could release a single-membraned packet of virions. Ironically,
then, a role for autophagic membranes in viral “envelope” formation
was ﬁrst identiﬁed in supposedly non-enveloped viruses. Recent data
have demonstrated a similar role for autophagy in an enveloped RNA
virus family, with the autophagy pathway used by Flaviviruses for
both particle maturation and release.
A pair of recent papers in the Journal of Virology introduced the idea
of a functional relationship between the autophagy pathway and EBV.
Hung et al. showed that the EBV transcription factor RTA activates tran-
scription of key autophagy genes, and that inhibition of autophagy re-
duces lytic progression of EBV (Hung et al., 2014). In a study
published a week later, Granato et al. showed that EBV subverts the au-
tophagy machinery to promote its own replication while inhibiting the
process of autophagic degradation (Granato et al., 2014). The latter is
not an unusual strategy; the maturation of the autophagosome into a
degradative autolysosome is tightly regulated. Coxsackievirus B3 has a
similar relationship with the machinery of autophagy, generating au-
tophagic structures without inducing degradation of their cargo
(Kemball et al., 2010). Therefore, the presence of autophagic mem-
branes does not necessarily indicate the presence of active autophagy.
Until now, however, the role of these membranes in EBV replication
was not understood.
In this issue,Münz and colleagues show that autophagicmembranes
are stabilized during EBV infection, which ﬁts with the ﬁndings of
Granato et al. that the pathway is activated but degradative throughput
is blocked (Nowag et al., 2014). Inhibition of autophagic pathways
increases EBV DNA levels in the cytosol while decreasing infectiousthe CC BY license (http://creativecommons.org/licenses/by/3.0/).
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and assembly. The authors go on to provide direct evidence that
autophagosome membranes are incorporated into traditional viral en-
velopes, identifying a key autophagymarker, the lipidated formof cellu-
lar LC3, in EBV particles. The authors come to the conclusion that EBV
subverts the machinery of autophagic membrane formation to form
its own second viral envelope.
Several questions remain. It is tempting, at ﬁrst thought, to imagine
that diverting a non-canonical secretory pathway for particle assembly
allows EBV to avoid the major secretory pathways used in immune re-
sponses. However, there is ample evidence that the autophagy pathway
actually feeds into multiple immune response pathways, particularly
theMHC Class II pathway, and late-expressed EBV proteins are present-
ed by MHC Class II in an autophagy-dependent manner (Puleston and
Simon, 2014). It appears that the abundant and ﬂexible source of mem-
branes provided by the autophagy machinery is usurped for pro-viral
purposes with little regard for their normal cellular function. The
trade-off for using autophagic membranes, of course, seems to be that
virus-derived peptides may then be presented on MHC molecules. Pre-
sumably this recognition by the immune system is worth the not-yet-
understood advantages provided by autophagic membranes.
The ﬁndings presented in this issuemake evenmore of a case for un-
derstanding the relationship between viruses and autophagy, and in
particular the advantages conferred by subverting the autophagic path-
way. It is certainly possible that proteins of the autophagy pathwaywill
make useful targets for therapeutics, to inhibit assembly of EBV and
other viruses. It is even possible that the presence of lipidated LC3 on
viral membranes could play a role in immune evasion, causing EBV par-
ticles to be recognized as part of the host — perhaps as autophagy-
derived exosomes, recently shown to be part of broad anti-viral re-
sponses (Delorme-Axford et al., 2013). In any case, the next several
years are certain to bring an increased focus on understanding themyr-
iad advantages of autophagic subversion by even more pathogens.
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